Axogen, Inc. Common Stock (AXGN) is a publicly traded Healthcare sector company. As of July 15, 2026, AXGN trades at $39.17 with a market cap of $2.10B and a P/E ratio of -62.04. AXGN moved +1.02% today. Year to date, AXGN is +18.45%; over the trailing twelve months it is +222.55%. Its 52-week range spans $9.22 to $46.95. Analyst consensus is strong buy with an average price target of $50.13. Rallies surfaces AXGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for AXGN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $39.17 |
| Market Cap | $2.10B |
| P/E Ratio | -62.04 |
| EPS | $-0.63 |
| Dividend Yield | 1.00% |
| 52-Week High | $46.95 |
| 52-Week Low | $9.22 |
| Volume | 8.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $238.10M |
| Net Income | $-31.45M |
| Gross Margin | 75.01% |
8 analysts cover AXGN: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.13.